.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
QuintilesIMS
Cipla
AstraZeneca
Cantor Fitzgerald
Medtronic
Fuji
Colorcon
Farmers Insurance
Covington

Generated: September 26, 2017

DrugPatentWatch Database Preview

TROVAN Drug Profile

« Back to Dashboard

Which patents cover Trovan, and what generic Trovan alternatives are available?

Trovan is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in TROVAN is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-one drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.

Summary for Tradename: TROVAN

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list24
Patent Applications: see list350
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TROVAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TROVAN
trovafloxacin mesylate
TABLET;ORAL020759-001Dec 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-002Dec 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TROVAN
trovafloxacin mesylate
TABLET;ORAL020759-002Dec 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TROVAN PRESERVATIVE FREE
alatrofloxacin mesylate
INJECTABLE;INJECTION020760-001Dec 18, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TROVAN/ZITHROMAX COMPLIANCE PAK
azithromycin dihydrate; trovafloxacin mesylate
FOR SUSPENSION, TABLET;ORAL050762-001Dec 18, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
TROVAN
trovafloxacin mesylate
TABLET;ORAL020759-001Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN
trovafloxacin mesylate
TABLET;ORAL020759-002Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN
trovafloxacin mesylate
TABLET;ORAL020759-002Dec 18, 1997► Subscribe► Subscribe
Pfizer
TROVAN
trovafloxacin mesylate
TABLET;ORAL020759-001Dec 18, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Covington
Julphar
QuintilesIMS
Chubb
Deloitte
Fish and Richardson
Daiichi Sankyo
Novartis
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot